Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaohua He

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Materials Today. Bio|February 12, 2026
Orchestrating the immuno-chondrogenic microenvironment via a bio-inorganic hybrid microsphere system for tendon-to-bone healingWencai Liu, Yuhao Yu, Hui Xu, et al.
Cancer Discovery|September 23, 2021
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring <i>FGF</i>/<i>FGFR</i> Aberrations: A Phase I Dose-Expansion StudyFunda Meric-Bernstam, Rastislav Bahleda, Cinta Hierro, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 9, 2024
Circadian Rhythm-Regulated ADSC-Derived sEVs and a Triphasic Microneedle Delivery System to Enhance Tendon-to-Bone HealingWei Song, Ying Guo, Wencai Liu, et al.
International Journal of Surgery (London, England)|February 19, 2026
All-suture soft anchors versus metal anchors in arthroscopic rotator cuff repair: a multicenter randomized clinical trialRenhao Yang, Qingsong Zhang, Chengyu Zhuang, et al.
Cancer Chemotherapy and Pharmacology|June 7, 2021
A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairmentMuhammad Wasif Saif, Carlos R Becerra, Marwan G Fakih, et al.
Future Oncology (London, England)|June 17, 2024
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancerLipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
The New England Journal of Medicine|January 18, 2023
Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic CholangiocarcinomaLipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
The New England Journal of Medicine|July 26, 2011
Apixaban with antiplatelet therapy after acute coronary syndromeJohn H Alexander, Renato D Lopes, Stefan James, et al.
Journal of Orthopaedic Translation|June 12, 2025
Chinese expert consensus on failure and revision after anterior cruciate ligament reconstructionTianwu Chen, Yongtao Mao, Lunhao Bai, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Materials Today. Bio|February 12, 2026
Orchestrating the immuno-chondrogenic microenvironment via a bio-inorganic hybrid microsphere system for tendon-to-bone healingWencai Liu, Yuhao Yu, Hui Xu, et al.
Cancer Discovery|September 23, 2021
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring <i>FGF</i>/<i>FGFR</i> Aberrations: A Phase I Dose-Expansion StudyFunda Meric-Bernstam, Rastislav Bahleda, Cinta Hierro, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 9, 2024
Circadian Rhythm-Regulated ADSC-Derived sEVs and a Triphasic Microneedle Delivery System to Enhance Tendon-to-Bone HealingWei Song, Ying Guo, Wencai Liu, et al.
International Journal of Surgery (London, England)|February 19, 2026
All-suture soft anchors versus metal anchors in arthroscopic rotator cuff repair: a multicenter randomized clinical trialRenhao Yang, Qingsong Zhang, Chengyu Zhuang, et al.
Cancer Chemotherapy and Pharmacology|June 7, 2021
A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairmentMuhammad Wasif Saif, Carlos R Becerra, Marwan G Fakih, et al.
Future Oncology (London, England)|June 17, 2024
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancerLipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
The New England Journal of Medicine|January 18, 2023
Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic CholangiocarcinomaLipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
The New England Journal of Medicine|July 26, 2011
Apixaban with antiplatelet therapy after acute coronary syndromeJohn H Alexander, Renato D Lopes, Stefan James, et al.
Journal of Orthopaedic Translation|June 12, 2025
Chinese expert consensus on failure and revision after anterior cruciate ligament reconstructionTianwu Chen, Yongtao Mao, Lunhao Bai, et al.
Pageof 11